Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Nucleic Acids: Liquid Biopsy for Early Cancer Detection

Circulating Nucleic Acids: Liquid Biopsy for Early Cancer Detection

Date: Wednesday, 28 March 2018 - Thursday, 29 March 2018
Location: Boston, USA


Keynote Speakers

Jan Lötvall

Jan Lötvall
Professor and Chairman of Krefting Research Centre, University of Gothenburg; Chief Scientific Officer, Codiak Biosciences; Founding President of ISEV

Shannon Stott

Shannon Stott
Assistant Professor, Massachusetts General Hospital & Harvard Medical School

Bob Carter

Bob Carter
Professor and Chief of Neurosurgery, Massachusetts General Hospital, Harvard Medical School

Gyongyi Szabo

Gyongyi Szabo
Professor & Vice Chair for Research, Department of Medicine, University of Massachusetts Medical School

Steven Pirie-Shepherd

Steven Pirie-Shepherd
Director, Pfizer

Jennifer Jones

Jennifer Jones
Staff Clinician, National Cancer Institute (NCI)

Balaji Panchapakesan

Balaji Panchapakesan
Associate Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI)

Anindya Dutta

Anindya Dutta
Harry F. Byrd Professor and Chair of Biochemistry and Molecular Genetics and Professor of Pathology, University of Virginia School of Medicine

Cheng-Ho Jimmy Lin

Cheng-Ho Jimmy Lin
Chief Scientific Officer, Natera

Walter Koch

Walter Koch
Vice President, Roche Molecular Systems

Peter  Quesenberry

Peter Quesenberry
Professor of Medicine, The Warren Alpert Medical School of Brown University

Daniel Chiu

Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington

Lucia Languino

Lucia Languino
Professor of Cancer Biology, Thomas Jefferson University

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas

Mike  Makrigiorgos

Mike Makrigiorgos
Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School

David Wong

David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

J. Carl Barrett

J. Carl Barrett
Vice President, Translational Sciences Oncology, AstraZeneca

Overview

Select Biosciences Fifth Annual Circulating Biomarkers World Congress 2018 brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference track focuses on the various classes of circulating nucleic acid biomarkers:
  • Circulating Nucleic Acids: Circulating Cell-Free DNA (cfDNA)
  • Circulating RNAs such as microRNAs in Biofluids
This conference features speakers from academia as well as industry addressing the following topic areas:
  • Technologies for Isolation and Characterization from Various Biofluids
  • Role in Cancer and Various Other Disease Classes (such as Cardiovascular Disease, CNS Disease and Beyond)
  • Biomarker Potential for Diagnostics Development
Registered delegates receive access to the co-located concurrent conference tracks, the co-located exhibit hall featuring companies providing tools and technologies address the circulating biomarkers field, as well as round-table discussions facilitating networking in specific topic areas.

Call for Papers

If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!

Oral Presentation Submission Deadline: 30 November 2017

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 16 March 2018

Agenda Topics

  • Circulating microRNAs, Other Classes of Circulating RNAs from Biofluids
  • Circulating Nucleic Acids and Circulating Tumor Cells (CTCs): Circulating Biomarkers for Liquid Biopsy Development
  • Circulating Nucleic Acids in Various Disease Classes
    • Cancer
    • Cardiovascular Disease
    • CNS and Neurodegenerative Diseases
    • Pregnancy and Reproductive Health
  • Circulating-Free DNA/Cell-Free DNA (cfDNA)
  • Liquid Biopsies for Early Cancer Detection

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Peter Benn, Professor Emeritus, Department of Genetics and Genome Sciences, University of Connecticut Health Center
John Castle, Executive Director, Vaccine Research and Translational Medicine, Agenus Switzerland Inc.
Colin Collins, Professor, University of British Columbia; Senior Scientist, Vancouver Prostate Centre
Ryan Dittamore, Vice President, Translational Research and Clinical Affairs, Epic Sciences
Brian Dougherty, Director, Translational Genomics, AstraZeneca Oncology
Taylor Jensen, Director, Research and Development, Sequenom (a LabCorp Company)
Qing Kang, Scientist, Progenity, Inc.
Y. Peng Loh, Chief and Senior Investigator, Section on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child health and Human Development, National Institutes of Health (NIH)
Abhijit Patel, Associate Professor, Yale University School of Medicine
Frank Slack, Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School
Rachel Tam, Senior Scientific Researcher, Oncology Biomarker Development, Genentech
Cha-Mei Tang, President and CEO, Creatv MicroTech
Allison Welsh, Senior Scientist, Foundation Medicine, Inc.


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2018-03-28 00:00:002018-03-29 00:00:00Europe/LondonCirculating Nucleic Acids: Liquid Biopsy for Early Cancer Detection SELECTBIOenquiries@selectbiosciences.com